Boston Scientific acquires Relievant Medsystems for $850M cash for the nerve ablation technology

By /

Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M (MedDevice) Boston Scientific(NYSE: BSX)+ announced today that it entered […]

Get access to full posts, newsletters, trends, and market reports for only subscribe for $1/day. 

Scroll to Top